Pathkey.ai Limited has released a press release.
Suspension from Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Pathkey.AI
- Request for Trading Halt
- Pause in Trading
- Successful Placement of Rights Issue Shortfall
- Opin Signs New $282K Patient Recruitment Contract
- Rights Offer Booklet
Later from Pathkey.AI
- Opyl receives non-binding offer for its Opin business
- Reinstatement to Quotation
- Opyl signs binding agreement for sale of Opin business
- Opyl Announces First Trial Gen Revenue & Customer
- Opyl Partners with L39 Capital to Launch AI Biotech Fund
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI